Home
About the Committees
Multi-region
Northern X and Y
Central
Upper South A and B
Lower South
Ethical Review in NZ
Role of Ethics Committees
System Overview
History
Committee Appointments: How to Apply
Ethical Review Process
What Research Requires Ethical Review
Other Review that may be Required
How to Apply
Amendments
Reporting Requirements
Challenging the Decisions of Ethics Committees
Study Participants
Forms
National Application Form for Ethical Review of a Research Project
Application Form for the Expedited Review of Obervational Studies
Progress Report and Final Report
Reporting of Serious Adverse Events (SAEs)
Guidance and Resources
Guidance on Ethical Research and Review
Consultation on Guidelines
Committee Resources
Related Committees and Organisations
Registers
Registration of Clinical Trials
Register of Human Embryonic Stem Cell Research
News and Updates
Contact Us
Health Committees
|
Accessibility
|
Site Map
|
Contact Us
New Zealand Health and Disability Ethics Committees
Search:
 
Print this
  
Email this
Registers
Registration of Clinical Trials
Information about the Australian and New Zealand Clinical Trials Registry (ANZCTR), and the World Health Organisation Standard on registration of all human medical research.
Australian and New Zealand Clinical Trials Registry (ANZCTR)
World Health Organisation Standard on registration of all human medical research
Further information
Where to register New Zealand trials
Australian and New Zealand Clinical Trials Registry (ANZCTR)
The
ANZCTR
(www.actr.org.au) has been established in response to growing international pressure for greater transparency and accountability by those carrying out clinical trials.
Researchers, research funders, policy-makers, medical practitioners, patients and the general public require a true picture of the evidence for a particular new treatment, drug, medical device or therapy to help guide research or to make treatment decisions.
Last year the International Committee of Medical Journal Editors (ICMJE) announced that from 1 July 2005 member publications - which include, The Lancet, The New England Journal of Medicine and the New Zealand Medical Journal - would only consider clinical trials for publication if the trial had been registered.
The ANZCTR meets the requirements of the ICMJE register policy and is consistent with the proposed WHO portal, which will allow a one-stop search of world-wide registers to improve fragmentation of current registries and establish standards on the scope and content of trial registration.
The ANZCTR is not limited to RCTs, and includes a wide definition of clinical trial. The Health Research Council is the coordinating agency for New Zealand and will work closely with the National Health and Medical Research Council (NHMRC), which has funded the establishment of the Register.
There is an ethical duty to participants to provide access to information about ongoing, completed and published clinical trials to allow informed decision-making. In the future, it is possible that the clinical trials registration process could be linked to ethics committee approval by requiring researchers to record the trial registration number on an ethics application form. The linking of the two processes would increase the robustness of the system and is a matter to be decided in the future.
Back to top
World Health Organisation Standard on registration of all human medical research
The World Health Organization (WHO) is urging research institutions and companies to register all medical studies that test treatments on human beings, including the earliest studies, whether they involve patients or healthy volunteers.
As part of the International Clinical Trials Registry Platform, a major initiative aimed at standardising the way information on medical studies is made available to the public through a process called registration, WHO is also recommending that 20 key details be disclosed at the time studies are begun.
The initiative seeks to respond to growing public demands for transparency regarding all studies applying interventions to human participants, known as clinical trials.
Before making the recommendations announced today, the Registry Platform initiative consulted with all concerned stakeholders, including representatives from the pharmaceutical, biotechnology and device industries, patient and consumer groups, governments, medical journal editors, ethics committees, and academia over a period of nearly two years.
‘Registration of all clinical trials and full disclosure of key information at the time of registration are fundamental to ensuring transparency in medical research and fulfilling ethical responsibilities to patients and study participants,’ said Dr Timothy Evans, Assistant Director-General of the World Health Organization.
Back to top
Although registration is voluntary, there is a groundswell of policies aimed at spurring registration of all clinical trials. In July 2005, for example, the International Committee of Medical Journal Editors, a group representing 11 prestigious medical journals, instituted a policy whereby a scientific paper on clinical trial results cannot be published unless the trial had been recorded in a publicly-accessible registry at its outset.
Some groups have raised concerns that these new requirements could jeopardize academic or commercial competitive advantage if they apply to preliminary trials of new interventions. Similar concerns have been voiced about the requirement to disclose certain items - such as the scientific title of the study, the name of the treatment being tested and the outcomes expected from the study - at the time of registration.
‘Our aim is to make clinical research transparent and enhance public trust in science, but we are engaged in a fair and open process with all stakeholders. We look forward to continued dialogue about trial registration and results reporting as we move forward with the Registry Platform,’ said Dr Ida Sim, Associate Director for Medical Informatics at the University of California, San Francisco and coordinator of the Registry Platform initiative.
The planned Registry Platform will not be a register itself, but rather will provide a set of standards for all registers. It has not only standardised what must be reported to register a trial but is creating a global trial identification system that will confer a unique reference number on every qualified trial.
Currently, there are several hundred registers of clinical trials around the world but little coordination among them. The Registry Platform seeks to bring participating registers together in a global network to provide a single point of access to the information stored in them.
Later this year, the WHO Registry Platform will launch a web-based search portal where scientists, patients, doctors, donors and anyone else who is interested can search among participating registers for clinical trials taking place or completed throughout the world.
Further information
See the frequently asked questions on the
World Health Organization website
(www.who.int)
Where to register New Zealand trials
New Zealand clinical trials may be registered on the
Australian and New Zealand Clinical Trials Registry
(www.actr.org.au).
Page last updated: 13 December 2007
Back to top
Ethics Committees:
Multi-region
Northern X and Y
Central
Upper South A and B
Lower South
View map of these regions
View meeting dates
Legal
newzealand.govt.nz
Minister of Health